Evaluation of Deficiency and Excessive Condition of Thrombin Burst Using Laboratory Tests
Thrombosis and Haemostasis · 01.10.2026 · 126 (10) · 0983-0990
DOI: 10.1055/a-2703-4175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.10.2026. Verfasst von Hideo Wada und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Mie Prefectural General Medical Center, Yokkaichi, Mie, Japan. Hauptthemen laut MEDLINE: Thrombin, Blood Coagulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: the Ministry of Health, Labour and Welfare of Japan, Ministry of Health, Labor and Welfare of Japan.
Abstract (Originalsprache)
Thrombin burst is an important mechanism for hemostasis, which is enhancement and amplification of the coagulation cycle, especially activation of coagulation factors XI, VIII, and V by thrombin on the activated platelets. Thrombin burst monitoring has been performed using hemostatic molecular markers, thrombin generation test (TGT), thromboelastography (TEG), and clot waveform analysis (CWA). In particular, CWA is a routine laboratory test that is neither time consuming nor expensive. Arterial thromboses, such as acute myocardial thrombosis and acute cerebral thrombosis, are associated with excessive condition of thrombin burst, and clotting time using a small amount of thrombin in CWA can detect activated or procoagulant platelets. Thrombin burst deficiency is caused by abnormalities of platelets such as thrombocytopenia or clotting factors such as hemophilia and acquired clotting factor deficiency, showing different CWA patterns. Patients with clotting factor VIII inhibitors are treated with bypass therapy, such as recombinant activated clotting factor VII and activated prothrombin complex concentrate, which can be monitored by CWA, TEG, or TGT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Medicine, Mie Prefectural General Medical Center, Yokkaichi, Mie, Japan.
- Mie Prefectural General Medical Center, Yokkaichi, Mie, Japan.
- Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Department of Biomedical Engineering, Osaka Institute of Technology, Asahiku, Osaka, Japan.
Förderung
- the Ministry of Health, Labour and Welfare of Japan
- Ministry of Health, Labor and Welfare of Japan
Zitieren
APA
Wada, H., Shiraki, K., Shimpo, H., & Miyata, T. (2026). Evaluation of Deficiency and Excessive Condition of Thrombin Burst Using Laboratory Tests. Thrombosis and Haemostasis, 126(10), 0983-0990. https://doi.org/10.1055/a-2703-4175
Vancouver
Wada H, Shiraki K, Shimpo H, Miyata T. Evaluation of Deficiency and Excessive Condition of Thrombin Burst Using Laboratory Tests. Thrombosis and Haemostasis. 2026;126(10):0983-0990. doi:10.1055/a-2703-4175
BibTeX
@article{Wada2026,
author = {Wada, Hideo and Shiraki, Katsuya and Shimpo, Hideto and Miyata, Toshiyuki},
title = {Evaluation of Deficiency and Excessive Condition of Thrombin Burst Using Laboratory Tests},
journal = {Thrombosis and Haemostasis},
year = {2026},
volume = {126},
number = {10},
pages = {0983--0990},
doi = {10.1055/a-2703-4175}
}
EUVIMED